Research Overview

A clear strategy for understanding, preventing and treating the cardiovascular effects of cancer therapy.

Our Research Strategy

Cancer treatments save lives, but they can also damage the heart. Our research strategy is built to close that gap: detecting cardiovascular risk early, understanding the biology that drives it, developing protective treatments, and supporting survivors over the long term. We pursue this through a tightly connected program that moves discoveries from the laboratory to the clinic and back again.

Doctor reviewing heart scans and ECG traces on a dual-monitor workstation

Key Focus Areas

Discovery Science

Mechanisms of cardiovascular toxicity from established and emerging cancer therapies

Cancer–heart interactions and molecular pathways linking cancer and cardiovascular disease

Discovery of new targets for cardiovascular protection and therapeutic development

Clinical and Population Science

Clinical cohorts and longitudinal follow-up across the cancer journey

Biomarkers, imaging and risk prediction for earlier detection and more personalised monitoring

Clinical studies evaluating cardiovascular prevention and treatment strategies

Implementation

Specialist and nurse-led cardio-oncology clinics co-located with cancer services

Physician-led dedicated telehealth cardio-oncology service for cancer patients in regional and rural NSW

Multidisciplinary models of care

Survivorship

Heart health embedded across the cancer survivorship continuum

A shared Cancer Survivorship Heart Health Plan for every stage of the cancer journey

Training and Education

Conferences, webinars and clinics

Education for patients, clinicians and researchers in cardio-oncology science

Our Impact

By bringing cardiology and oncology together, our work helps clinicians identify at-risk patients sooner, protect hearts during treatment, and give cancer survivors the best possible long-term outcomes. Every project is designed to translate into real benefit at the bedside.

Get in Touch

Interested in collaborating with us or learning more about our clinical and research program? We’d love to hear from you.